New two-dose HIV vaccine strategy shows promise for stronger immune response

One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, allowing it to evade the antibody response generated by vaccines.

Olympics 2024 Anti-Doping: Why Innovation in Testing Is Key

Gabe Baida, Executive Director at InnoVero As we approach the 2024 Summer Olympics, ensuring a clean game is a major priority for the International Olympic

July 17, 2024

Psyence Biomedical Announces Favorable Result of Nasdaq Listing Qualifications Hearing | Psychedelic Invest

NEW YORK, Nov. 20, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced the favorable outcome of the Nasdaq Listing Qualifications Hearing

November 20, 2024

Psychedelics Financial Reporting Calendar 2024

The TDR Three Takeaways: Monitor next quarter’s earnings for Psychedelics companies with our detailed calendar. Stay updated on upcoming quarterly reporting timelines in the Psychedelic

January 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.